Harmony Biosciences Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$261,280	$215,387	$243,776	$239,455
Gross Profit	198,082	170,875	175,231	179,805
EBITDA	96,345	48,889	51,738	73,458
EBIT		42,921	44,306	67,490
Net Income	75,431	32,488	22,486	50,865
Net Change In Cash	261,280	215,387	243,776	239,455
Free Cash Flow	92,432	27,760	126,044	108,663
Cash	549,769	589,398	752,502	646,999
Basic Shares	58,769	58,776	58,696	58,717

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$868,453	$714,734	$582,022	$437,855
Gross Profit	670,111	557,919	460,786	354,374
EBITDA	255,048	233,412	221,512	146,866
EBIT	229,713	209,300	197,153	123,481
Net Income	158,687	145,493	128,853	181,468
Net Change In Cash	868,453	714,734	582,022	437,855
Cost of Revenue				9,475
Free Cash Flow	347,889	218,668	219,075	144,294
Cash	752,502	453,001	311,660	243,784
Basic Shares	58,544	57,870	60,372	61,097